MENU
MAY 10, 2017 7:00 AM PDT

Basic Concepts in Transient Expression using 293 and CHO cells

Speaker
  • Associate Director, Cell Biology, Life Sciences Solutions Group Thermo Fisher Scientific
    Biography
      Henry is associate director of product management, responsible for the Gibco and Invitrogen-branded protein expression portfolio at Thermo Fisher Scientific. He has directed or guided development of such products as Lipofectamine® LTX, Lipofectamine® RNAiMAX, Lipofectamine® 3000, the FreeStyle™ MAX CHO Expression System, the Expi293™ Expression System and the ExpiCHO Expression System. Henry previously worked for small biotech companies in gene delivery and gene therapy. He received his Ph.D. from Harvard University and did his post-doctoral training at the University of Pennsylvania.

    Abstract

    HEK293 and CHO cells are the primary cell lines used in rapid, scalable suspension culture systems for transient protein expression. This presentation provides a primer on fundamental concepts and materials used for transient expression and key differences to consider when using 293 or CHO cells.


    Show Resources
    MAY 10, 2017 7:00 AM PDT

    Basic Concepts in Transient Expression using 293 and CHO cells


    Specialty

    Biotechnology

    Cancer Research

    Cell Biology

    Molecular Biology

    Antibodies

    Cell Culture

    Genetics

    Immunology

    Neuroscience

    Cancer Therapeutics

    Medicine

    Infectious Disease

    Gene Expression

    Research And Development

    Biology

    Geography

    North America43%

    Asia24%

    Europe19%

    South America11%

    Africa2%

    Registration Source

    Website Visitors100%

    Job Title

    Student24%

    Research Scientist24%

    Scientist14%

    Post Doc10%

    Facility/Department Manager6%

    Executive6%

    Medical Doctor/Specialist6%

    Educator/Faculty4%

    Pharmacist2%

    Medical Laboratory Technician2%

    Clinical Laboratory Scientist2%

    Organization

    Academic Institution19%

    Biotech Company9%

    Life Science Company6%

    Government4%

    Research Institute4%

    Clinical Laboratory2%

    Contract Research Organization (Cro)2%

    Ambulatory Care2%

    Manufacturer - Other2%

    Pharmaceutical Company2%

    Media2%

    Medical School2%


    Show Resources
    Show Resources
    Attendees
    • See more
    Connect with us